Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIb Study Assessing the Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells for Knee Cartilage Injury

NCT05016011 is registered in ClinicalTrials.gov with Cytopeutics Sdn. Bhd. as lead sponsor.

NCT NCT05016011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05016011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIb Study Assessing the Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells for Knee Cartilage Injury
Lead sponsor
Cytopeutics Sdn. Bhd.
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2020
Completion date
March 21, 2022
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee